102 related articles for article (PubMed ID: 26035204)
41. Effects of N-acetyl cysteine on cognitive function in bipolar disorder.
Dean OM; Bush AI; Copolov DL; Kohlmann K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Berk M
Psychiatry Clin Neurosci; 2012 Oct; 66(6):514-7. PubMed ID: 23066769
[TBL] [Abstract][Full Text] [Related]
42. A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania.
Magalhães PV; Dean OM; Bush AI; Copolov DL; Malhi GS; Kohlmann K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Berk M
Aust N Z J Psychiatry; 2013 Jun; 47(6):564-8. PubMed ID: 23493756
[TBL] [Abstract][Full Text] [Related]
43. The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm.
Niemi TT; Munsterhjelm E; Pöyhiä R; Hynninen MS; Salmenperä MT
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):29-34. PubMed ID: 16607076
[TBL] [Abstract][Full Text] [Related]
44. Effect of N-acetylcysteine and/or deferoxamine on oxidative stress and hyperactivity in an animal model of mania.
Valvassori SS; Petronilho FC; Réus GZ; Steckert AV; Oliveira VB; Boeck CR; Kapczinski F; Dal-Pizzol F; Quevedo J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1064-8. PubMed ID: 18403082
[TBL] [Abstract][Full Text] [Related]
45. Effects of alpha-phenyl-N-tert-butyl nitrone and N-acetylcysteine on hydroxyl radical formation and dopamine depletion in the rat striatum produced by d-amphetamine.
Wan FJ; Tung CS; Shiah IS; Lin HC
Eur Neuropsychopharmacol; 2006 Feb; 16(2):147-53. PubMed ID: 16061357
[TBL] [Abstract][Full Text] [Related]
46. [Depression following mania: A specific entity in bipolar disorder?].
Masson M; Henry C
Encephale; 2017 Feb; 43(1):1-2. PubMed ID: 28196597
[No Abstract] [Full Text] [Related]
47. N-acetylcysteine attenuates copper overload-induced oxidative injury in brain of rat.
Ozcelik D; Uzun H; Nazıroglu M
Biol Trace Elem Res; 2012 Jun; 147(1-3):292-8. PubMed ID: 22246790
[TBL] [Abstract][Full Text] [Related]
48. N-Acetylcysteine for the prevention of renal dysfunction in high-risk patients undergoing coronary bypass graft surgery: an unfulfilled promise?
Filep JG
Crit Care Med; 2007 May; 35(5):1431-3. PubMed ID: 17446744
[No Abstract] [Full Text] [Related]
49. Deserves a hearing? A case report of remitting tinnitus with N-acetyl cysteine.
Dean OM; Jeavons S; Malhi GS; Cotton SM; Tanious M; Kohlmann K; Hewitt K; Moss K; Allwang C; Schapkaitz I; Robbins J; Cobb H; Dodd S; Bush A; Berk M
Afr J Psychiatry (Johannesbg); 2013 Jul; 16(4):238, 240. PubMed ID: 24051561
[No Abstract] [Full Text] [Related]
50. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
Thiele H; Hildebrand L; Schirdewahn C; Eitel I; Adams V; Fuernau G; Erbs S; Linke A; Diederich KW; Nowak M; Desch S; Gutberlet M; Schuler G
J Am Coll Cardiol; 2010 May; 55(20):2201-9. PubMed ID: 20466200
[TBL] [Abstract][Full Text] [Related]
51. N-acetylcysteine in COPD may be beneficial, but for whom?
Cazzola M; Matera MG
Lancet Respir Med; 2014 Mar; 2(3):166-7. PubMed ID: 24621673
[No Abstract] [Full Text] [Related]
52. N-acetylcysteine for COPD: the evidence remains inconclusive.
Turner RD; Bothamley GH
Lancet Respir Med; 2014 Apr; 2(4):e3. PubMed ID: 24717631
[No Abstract] [Full Text] [Related]
53. N-acetylcysteine for the treatment of glutathione deficiency and oxidative stress in schizophrenia.
Shungu DC
Biol Psychiatry; 2012 Jun; 71(11):937-8. PubMed ID: 22579304
[No Abstract] [Full Text] [Related]
54. N-acetylcysteine for chronic obstructive pulmonary disease?
Lavietes MH
Respiration; 1999; 66(6):491-2. PubMed ID: 10847827
[No Abstract] [Full Text] [Related]
55. N-acetylcysteine for COPD: the evidence remains inconclusive--authors' reply.
Zheng JP; Zhong NS
Lancet Respir Med; 2014 Apr; 2(4):e3-4. PubMed ID: 24717632
[No Abstract] [Full Text] [Related]
56. Effects of N-acetylcysteine on hepatic blood flow and function.
Ott P
Crit Care Med; 1998 Feb; 26(2):415. PubMed ID: 9468182
[No Abstract] [Full Text] [Related]
57. Positive effect of N-acetylcysteine in theophylline intoxication.
Kisters K; Cziborra M; Funke C; Tokmak F; Hausberg M
Clin Nephrol; 2007 Oct; 68(4):266. PubMed ID: 17969498
[No Abstract] [Full Text] [Related]
58. Treating trichotillomania across the lifespan.
Woods DW
J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):223-4. PubMed ID: 23452677
[No Abstract] [Full Text] [Related]
59. Energy, oxidative stress, and inflammation in the colon.
Harty RF
Dig Dis Sci; 2013 Dec; 58(12):3386-8. PubMed ID: 23979440
[No Abstract] [Full Text] [Related]
60. Possible mechanisms for treatment heterogeneity in clinical trials of adjunctive N-acetylcysteine for bipolar depression.
Brown A; Glue P
Bipolar Disord; 2022 Mar; 24(2):213. PubMed ID: 34762364
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
